Navigation Links
Success for first outdoor, large-scale algae-to-biofuel research project in Nevada
Date:1/29/2009

RENO, Nev. The first real-world, demonstration-scale project in Nevada for turning algae into biofuel has successfully completed the initial stage of research at the University of Nevada, Reno. The project is on track to show the process is an economical, commercially viable renewable energy source in Nevada.

University researchers have harvested their first outdoor cold-weather crop of algae as part of their collaborative algae-to-biofuels project with their industry partners Enegis, LLC and Bebout and Associates.

The project, using one of two 5,000-gallon ponds at the University's greenhouse complex on Valley Road in Reno, produced several hundred gallons of concentrated algal slurry. The research has demonstrated that, with the proper technology and species of algae, it is possible to grow algae outdoors year-round in Nevada. The pond was inoculated with a "starter" culture and then the cells grow out until they reach a plateau or stationary phase, which takes two to three weeks. The algae thrived in the outdoor pond despite nighttime temperatures that fell into the low 20s.

"We'll be analyzing the algae for starches and lipids, the components that can be used for fuel," said Professor John Cushman, Department of Biochemistry & Molecular Biology. A conservative estimate for this harvest is 30 percent lipids and five percent starches on a dry weight basis, less on a fresh weight basis." The professor oversees the venture along with fellow faculty members Jeffrey Harper and David Shintani, two graduate students Leyla Hernandez-Gomez and Mark Lemos, and research associate Rebecca Albion.

The goal is to develop a hardy variety of salt-loving algae as alternative biofuel feedstock, which produces more than half its weight in oil as well as developing a practical process to grow, concentrate and harvest the algae. The alga variety harvested was selected and cultured by the University, and future varieties will be develop
'/>"/>

Contact: Mike Wolterbeek
awolterbeek@unr.edu
University of Nevada, Reno
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Layered approach may yield stronger, more successful bone implants
2. NASA keeps eye on ozone layer amid Montreal Protocols success
3. Life on Mars pregnancy test successfully launched
4. New book presents successful strategies for probing genetic variation
5. A new milestone in the GMES Space Component Program successfully achieved
6. MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
7. Age increases chance of success as two-timer
8. Teamwork improves learning and career success
9. Researchers successfully simulate photosynthesis and design a better leaf
10. Predicting growth hormone treatment success
11. Study links success of invasive Argentine ants to diet shifts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Success for first outdoor, large-scale algae-to-biofuel research project in Nevada
(Date:4/8/2015)... CHARLOTTE, N.C. , April 8, 2015 /PRNewswire/ ... technology solutions and services, and Morpho, a leading ... in partnership to produce the market,s most advanced ... Infinisource,s iSolved NXG time clock is setting ... attendance and labor data for the small and ...
(Date:4/2/2015)... 2015 According to preliminary estimates ... somewhat higher than 125 MSEK. This exceeds the guidance ... that revenues for Q1 2015 would be in line ... Q4 2014. The operating result for the first quarter ... interim report will as previously communicated be published on ...
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... an increasing health problem all over the world. Bacteria ... pharmaceuticals that can combat this threat are in great ... chemical compound in the garlic plant that neutralises resistant ... demonstrates that ajoene the substance present in garlic ...
... as a way to represent the impact of human ... industry over the last two decades. Since the ... it was introduced by researchers William E. Rees and ... a range of complicated phenomena as a single metric, ...
... Mosaic , a new digital publication dedicated to exploring the ... 2014. Mosaic will carry long-form features, articles ... its impact on society. All articles will be free to ... Commons licence so that it can be reproduced and distributed ...
Cached Biology News:Garlic counteracts virulent bacteria 2What good are footprints? 2What good are footprints? 3New digital publication Mosaic explores the science of life 2
(Date:4/27/2015)... BARCELONA, Spain , April 27, 2015  Together ... during the 3rd ESTRO Forum in Barcelona ... Hope, a nonprofit organization with the mission to improve ... Radiating Hope believes that no patient should ... is not affordable. Consequently, it cooperates with hospitals and ...
(Date:4/24/2015)... 24, 2015 Leading Regenerative Veterinary ... its allogeneic stem-cell product development program and changes ... the corporate strategic direction. , “I am extremely ... stem cell development program has been kicked into ... manufacturing facility and hiring of our new Director ...
(Date:4/24/2015)... , April 24, 2015  Navitas Life Sciences is delighted ... Head of Clinical and Regulatory Services. Shalabh is a proven ... co-founder and CEO of Kinapse, as well as a Strategy ... Logo - http://photos.prnewswire.com/prnh/20150423/201261LOGO ... commented "I am delighted to welcome Shalabh into this ...
(Date:4/23/2015)... Dora, Florida (PRWEB) April 23, 2015 ... that it intends to conduct a groundbreaking pilot ... begin to be reversed in as little as ... the science of metabolic and nutritional medicine—will aggressively ... that cripple and destroy our aging brain. These ...
Breaking Biology Technology:Elekta helps raise $33,000 to bring radiation treatment to developing countries 2Elekta helps raise $33,000 to bring radiation treatment to developing countries 3Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma 2Shalabh Kumar Joins Navitas Life Sciences to Lead their Clinical and Regulatory Services Teams 2New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3
... Announces Revised Operating Plan to Respond to NEBIDO Delay, ... IDEV ) today announced that it has received,an ... (FDA) for,NEBIDO(R) related to a New Drug Application (NDA) ... on June 27, 2008, indicated that the,application may be ...
... Company to Commercialize ... Novel Technology from UC Davis, BOSTON, ... early stage university business ventures, has,established RF Biocidics, Inc., to ... UC Davis., The newly formed RF Biocidics, Inc. is ...
... 30 Raptor,Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), ... private placement of 20 million units,constituting an aggregate ... and two-year warrants to purchase 10 million shares ... Company raised $9.3 million in,net proceeds from the ...
Cached Biology Technology:Indevus Receives Approvable Letter from FDA for NEBIDO(R) 2Indevus Receives Approvable Letter from FDA for NEBIDO(R) 3Indevus Receives Approvable Letter from FDA for NEBIDO(R) 4Indevus Receives Approvable Letter from FDA for NEBIDO(R) 5Indevus Receives Approvable Letter from FDA for NEBIDO(R) 6Indevus Receives Approvable Letter from FDA for NEBIDO(R) 7Allied Minds Launches Novel Disinfectant/Disinfestant Technology Start-up With UC Davis 2Raptor Pharmaceuticals Closes $10 Million Private Placement 2Raptor Pharmaceuticals Closes $10 Million Private Placement 3Raptor Pharmaceuticals Closes $10 Million Private Placement 4
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Request Info...
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
...
Biology Products: